Back to fundsView filing
Jones Hill Capital LP
hedge fundUpdated 28 days agoManaged by Jones Hill Capital Lp • Latest filing Q2 2026
Portfolio value
$470.4M
Q2 2026
Filings
2
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Top holdings
29 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | B BMRN BIOMARIN PHARMACEUTICAL INC | $81.9M | 1.43M | 17.42% | — |
| 2 | G GILD GILEAD SCIENCES INC | $43.3M | 343.0K | 9.21% | — |
| 3 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $28.6M | 1.09M | 6.07% | — |
| 4 | M MDGL MADRIGAL PHARMACEUTICALS INC | $28.2M | 52.5K | 6.00% | — |
| 5 | B BCAX BICARA THERAPEUTICS INC | $26.5M | 892.6K | 5.63% | — |
| 6 | R RLMD RELMADA THERAPEUTICS INC | $25.3M | 3.66M | 5.38% | — |
| 7 | T TRVI TREVI THERAPEUTICS INC | $25M | 1.34M | 5.31% | — |
| 8 | P PHVS PHARVARIS N V | $23.4M | 677.9K | 4.98% | — |
| 9 | X XENE XENON PHARMACEUTICALS INC | $22.2M | 367.9K | 4.72% | — |
| 10 | A ANIP ANI PHARMACEUTICALS INC | $19.4M | 233.8K | 4.11% | — |
| 11 | I IMCR IMMUNOCORE HLDGS PLC | $16.3M | 512.9K | 3.46% | — |
| 12 | A AMLX AMYLYX PHARMACEUTICALS INC | $16.1M | 894.1K | 3.41% | — |
| 13 | I INSM INSMED INC | $13M | 122.4K | 2.77% | — |
| 14 | ? N/A NUVALENT INC | $12.2M | 98.4K | 2.58% | — |
| 15 | C CAPR CAPRICOR THERAPEUTICS INC | $10.1M | 420.8K | 2.15% | — |
| 16 | A ACRS ACLARIS THERAPEUTICS INC | $9.3M | 1.76M | 1.98% | — |
| 17 | ? N/A IMMUNIC INC | $8.3M | 539.8K | 1.76% | — |
| 18 | O ORIC ORIC PHARMACEUTICALS INC | $8.1M | 747.3K | 1.72% | — |
| 19 | T TNXP TONIX PHARMACEUTICALS HLDG C | $8M | 625.4K | 1.70% | — |
| 20 | S SNDX SYNDAX PHARMACEUTICALS INC | $7.4M | 340.0K | 1.58% | — |